Diffusion weighted imaging best discriminates PD from MSA‐P: A comparison with tilt table testing and heart MIBG scintigraphy
- 19 June 2007
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 22 (12), 1771-1776
- https://doi.org/10.1002/mds.21614
Abstract
Both diffusion weighted magnetic resonance imaging (DWI) of the basal ganglia and meta‐iodobenzylguanidin (MIBG) scintigraphy of the heart have been reported useful in the differential diagnosis of patients with Parkinson's disease (PD) vs. the parkinson variant of multiple system atrophy (MSA‐P). Their diagnostic value, however, has never been directly compared in patients with parkinsonism and autonomic dysfunction. We have studied 9 patients with PD and 9 patients with MSA‐P matched for age and disease severity. Regional trace of the diffusion tensor values were determined in the putamina. Cardiac MIBG uptake was quantified by comparing regions of interest over heart and mediastinum Heart/Mediastinum (H/M) ratio. Furthermore, all patients underwent tilt testing. PD patients showed significantly lower H/M ratios than normal controls; however, there was considerable overlap between the two patient groups. We did not detect any significant differences of blood pressure response to passive tilt between the two patient groups. Sensitivity of MIBG scintigraphy versus DWI for the differentiation of MSA‐P from PD was 55.6% vs. 100%, specificity 88.8% vs. 100%, and area under the curve 0.802 vs. 1.000. Our data suggest that DWI is superior to both tilt table testing and MIBG scintigraphy in the differential diagnosis of PD versus MSA‐P. © 2007 Movement Disorder SocietyKeywords
This publication has 38 references indexed in Scilit:
- The diagnosis of Parkinson's diseaseThe Lancet Neurology, 2006
- Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PDJournal of the Neurological Sciences, 2004
- Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder serviceBrain, 2002
- The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromesClinical Autonomic Research, 2001
- Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromesMovement Disorders, 2001
- Sympathetic skin response and cardiovascular autonomic function tests in Parkinson's disease and multiple system atrophy with autonomic failureMovement Disorders, 2000
- Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG–SPECTJournal of the Neurological Sciences, 2000
- Cardiac uptake of [ 123 I]MIBG separates Parkinson’s disease from multiple system atrophyNeurology, 1999